Physician profile
Tracy C Chavez
NPI 1932229614
$1,501.37
in general payments reported to CMS, 2019-2025
24 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $430 · 2022: $140 · 2023: $222 · 2024: $386 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $932.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $932.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $322.68 | 2021-2024 | |
| Glaxosmithkline, LLC. | $321.32 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $129.63 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $90.73 | 2021-2025 | Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $89.20 | 2024-2025 | Airsupra, Farxiga |
| Astellas Pharma US INC | $58.74 | 2024 | Veozah |
| Janssen Pharmaceuticals, INC | $54.88 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.65 | 2022-2025 | |
| Exact Sciences Corporation | $43.32 | 2023 | Cologuard Collection Kit |
| Abbott Laboratories | $37.51 | 2021-2024 | Freestyle Libre 3 |
| Organon LLC | $35.97 | 2021-2022 | |
| Eisai INC. | $32.92 | 2021 | |
| Phadia US INC. | $31.68 | 2023-2025 | Immunocap |
| Genzyme Corporation | $29.93 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $21.94 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $21.85 | 2024 | |
| Si-Bone, INC. | $19.24 | 2023 | |
| Antares Pharma, INC. | $17.81 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.08 | 2023 | Ofev |
| Merck Sharp & Dohme LLC | $16.10 | 2021 | |
| Xeris Pharmaceuticals, INC. | $15.55 | 2023 | Gvoke Hypopen |
| Inspire Medical Systems, INC. | $15.50 | 2025 | Inspire |
| Kyowa Kirin, INC. | $15.18 | 2024 | |
| Philips North America LLC | $13.96 | 2024 | (Ck7) Extended Holter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Chavez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.